Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for prevention of contrast-induced nephropathy
IRCT201205305113N3Phase 3Completed
- Sponsor
- Nephrology Research Center
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in contrast-induced nephropathy (CIN), sponsored by Nephrology Research Center. Started Sep 2012; status: completed.
02
Drugs
acetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT201205305113N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205305113N3.